Neuroprotective effect of Z-Ligustilide against permanent focal ischemic damage in rats

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 2, 2007, Pages 309-312

  Peng, Hai Yan ^a   Du, Jun Rong ^a   Zhang, Guang Yi ^a   Kuang, Xi ^a   Liu, Yan Xin ^a   Qian, Zhong Ming ^b   Wang, Chen Yuan ^b  

^a SICHUAN UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

3 n alkyphthalide derivative; Brain edema; Focal cerebral ischemia; Ligustilide (LIG); Neuroprotective agent; Radix Angelica sinensis (Danggui)

Indexed keywords

LIGUSTILIDE; TRIPHENYLTETRAZOLIUM;

ANGELICA SINENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT; STAINING;

4-BUTYROLACTONE; ANIMALS; BODY TEMPERATURE; BRAIN EDEMA; BRAIN ISCHEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33846948242     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.309     Document Type: Article

References (28)

1. Warlow C. P., Lancet, 352, SIII1-SIII4 (1998).
2. Du R. J., Bai B., Yu Y., Wang Ch. Y., Qian Ah. M., Zhongguo Zhong Yao Za Zhi, 30, 1400-1406 (2005).
3. Takashi Y., Hokkaidoritsu Eisei Kenkyusyoho, 32, 12-16 (1982).
4. Kuang X., Yao Y., Du J. R., Liu Y. X., Wang Ch. Y., Qian Zh. M., Brain Res., 1102, 145-153 (2006).
5. Zhang G. Y., Du J. R., Kuang X., Yao Y., Liu Y. X., Wang Ch. Y., Qian Zh. M., West China J. Pharm. Sci., 21, 114-117 (2006).
6. Karpiak S. E., Tagliavia A., Wakade C. G., Annu. Rev. Pharmacol. Toxicol., 29, 403-414 (1989).
7. Li Q., Stephenson D., Exp. Neurol., 177, 531-537 (2002).
8. Joshi C. N., Jain S. K., Murthy P. S. R., Brain Res. Protoc., 13, 11-17 (2003).
9. Belayev L., Liu Y., Zhao W., Busto R., Ginsberg M. D., Stroke, 32, 553-560 (2001).
10. Menzies S. A., Hoff J. T., Betz A. L., Neurosurgery, 31, 100-107 (1992).
11. Chang Q., Wang X. L., Acta Pharmaceut. Sin., 24, 796-804 (2003).
12. Liu X. G., Feng Y. P., Acta Pharmaceut. Sin., 30, 896-903 (1995).
13. Zhang L. Y., Feng Y. P., Acta Pharmaceut. Sin., 31, 18-23 (1996).
14. Cui L. Y., Li S. W., Lu C. Z., Dong Q., Dong P., Shi L. F., Huang J. Zh., Mao Sh. Y., Zhang Ch. D., Cao Y. P., Nie Y. X., Wang W. Zh., Liang Q. Ch., Yang Ch. X., Dong W. W., Li G. Q., Peng G. G., Luo Zh. M., He L., Wang Q., Han J. L., Huang R. X., Li L., Li Ch. Y., Meng Zh. Zh., Chin. J. Cerebrovasc. Dis., 18, 112-115 (2005).
15. Wang H. Y., Huang H. Y., Chin. J. Med. Guide, 5, 448 (2003).
16. Heo H. J., Han S. W., Lee S. K., Free Radic. Biol. Med., 39, 51-70 (2005).
17. Trickler W. J., Mayhan W. G., Miller D. W., Brain Res., 1048, 24-31 (2005).
18. Ding-Zhou L., Marchand-Verrecchia C., Palmier B., Croci N., Chabrier P. E., Plotkine M., Marqaill I., J. Pharmacol. Exp. Ther., 306, 588-594 (2003).
19. Liu L., Ning Z. Q., Shan S., Zhang K., Deng T., Lu X. P., Cheng Y. Y., Planta Med., 71, 808-813 (2005).
20. Yao Y., Du J. R., Bai B., Wang Ch. Y., Qian Zh. M., Nat. Prod. Res. Dev., 15, 751-755 (2006).
21. Zhao Q., Memezawa H., Smith M. L., Siesjo B. K., Brain Res., 649, 253-259 (1994).
22. Legos J. J., Mangoni A. A., Read S. J., Cambell C. A., Irving E. A., Roberts J., Barone F. C., Parsons A. A., J. Neurosci. Meth., 113, 159-166 (2002).
23. Li F., Omae T., Fisher M., Stroke, 30, 2464-2471 (1999).
24. Chen Q., Chopp M., Bodzin G., Chen H., J. Cereb. Blood. Flow Metab., 13, 389-394 (1993).
25. Dietrich W. D., Halley M., Valdes I., Busto, R., Acta Neuropathol., 81, 615-625 (1991).
26. Corbett D., Hamilton M., Colbourne F., Exp. Neurol., 163, 200-206 (2000).
27. Maier C. M., Ahern K., Cheng M. L., Lee J. E., Yenari M. A., Steinberg G. K., Stroke, 29, 2171-2180 (1998).
28. Xie F. X., Tao J. Y., Shan Xi New Med., 14, 59-62 (1985).